GE Healthcare Buys Vital Signs For $990mm
This Week's Device Deals At-A-Glance repinted from Strategic Transactions - July 2008
GE Healthcare has agreed to buy Vital Signs (anesthesia, respiratory, sleep therapy, and emergency medicine single-patient use products) for $990mm or $74.50 in cash (a 27% premium) for each VS common share. Check out this week's other top deals.
Acquisition
GE Healthcare buys Vital Signs for $990mm in cash · July 2008
Alliance
- 3M uses Greystone's technology in wound dressings · July 2008
- IDev to sell YMed's VascuTrak 2 in North America and Europe · June 2008
Financing
- ALung Technologies raises $1mm of potential $2.5mm financing · June 2008
- Arbel Medical raises $4.5mm through second financing round · July 2008
- Dexela raises £2.6mm through second round · July 2008
- Healionics brings in first part of its Series B round · June 2008
- Spineology raises $7.5mm in private financing · July 2008
GE Healthcare buys Vital Signs for $990mm in cash · July 2008
VS will become part of GE Healthcare's Clinical Systems business unit, which offers technologies for monitoring patients, delivering anesthesia, and providing acute respiratory care. VS reported 2007 earnings of $19mm and $205mm in revenues; GE says it is acquiring the company because of its annual double-digit sales growth. Vital Signs markets anesthesia products including the Disposa-View head positioning device, breathing circuits, face masks, filters, CPAP systems for obstructive sleep apnea, and GAS general anesthesia systems; respiratory devices such as blood gas samplers, C-CO2 indicators, BabyBlue II infant resuscitator, and Babysafe hyperinflation system, and its neonatal intensive care face masks and Kurtis MSD meconium section device. VS also sells blood pressure cuffs for the critical care market, CPR training mannequins, and intubation packs for emergency care. In the last six months GE spent $702mm for Whatman (blood and research products) and bought privately held VersaMed (ventilators).
About Strategic Transactions - The Device Deal Database
Our proprietary database is designed for medical technology professionals and investors that need to stay current on the latest industry alliances, financing, mergers & acquistions and other strategic partnerships.
Find out more about what Strategic Transactions - The Device Deal Database can do for you.
Strategic Transactions - The Device Deal Database provides expanded information, including:
- Comprehensive Deal Records
- Complete Financial Information
- Extensive Company Profiles
- Access to important SEC Documents
- Links to related articles
Contact: James DeFalco at: +1 (203) 838-4401 x104 or [email protected].
